Cancer Therapeutics and Biotherapeutics Market Report 2024 (Global Edition)

Global Cancer Therapeutics and Biotherapeutics Market Report 2024 Market Size Split by Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head ...

Cancer Therapeutics and Biotherapeutics Market Report Description

We have various report editions of Cancer Therapeutics and Biotherapeutics Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Cancer Therapeutics and Biotherapeutics Market Insights Video

Competitive Landscape of the Cancer Therapeutics and Biotherapeutics Market

The market for cancer therapies and biotherapeutics is extremely competitive, with Roche, Bristol-Myers Squibb, Merck, Pfizer, and Novartis among the leading companies in terms of drug research and innovation. With significant investments in R&D and strategic partnerships, these businesses concentrate on biologics, targeted treatments, and sophisticated immunotherapies. New technologies and specialized cancer therapies are two more ways that up-and-coming biotech companies add to the competitive scene. This changing market is characterized by fierce rivalry driven by rapid innovations, frequent new product releases, and regulatory approvals.

In March 2024, Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical firm developing next-generation radioconjugates (RCs), and AstraZeneca, a pharmaceutical company, struck a final agreement to acquire the latter. The acquisition is a major step toward AstraZeneca's mission to transform cancer treatment and patient outcomes by substituting more customized treatments for traditional regimens like chemotherapy and radiation. (Source: https://www.astrazeneca.com/media-centre/press-releases/2024/astrazeneca-to-acquire-fusion.html) In February 2024, an estimated 9.7 million people died from cancer in 2022, and there were 20 million new cases. 53.5 million people were expected to have survived a cancer diagnosis within five years. In their lifetime, 1 in 5 people will have cancer, and 1 in 9 men and 1 in 12 women will pass away from it. (Source: https://www.who.int/news/item/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services) In July 2022, Ryvu Therapeutics S.A. and Exelixis, Inc. signed an exclusive license deal aimed at creating targeted treatments using Ryvu's STING (STimulator of INterferon Genes) technology. Through this partnership, Exelixis' experience in antibody engineering, antibody-drug conjugate (ADC) technology, and its history of developing and launching oncology treatments will be combined with Ryvu's small molecule STING agonists and STING biology knowledge. (Source:https://ir.exelixis.com/news-releases/news-release-details/exelixis-and-ryvu-therapeutics-establish-exclusive-license) In May 2021, the U.S. Food and Drug Administration (FDA) authorized Amgen's LUMAKRAS (sotorasib) to treat adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with a KRAS G12C mutation. (Source:https://www.amgen.com/newsroom/press-releases/2021/05/fda-approves-lumakras-sotorasib-the-first-and-only-targeted-treatment-for-patients-with-kras-g12cmutated-locally-advanced-or-metastatic-nonsmall-cell-lung-cancer)

Top Companies Market Share in Cancer Therapeutics and Biotherapeutics Industry: (In no particular order of Rank)

• Amgen Inc.
• Bristol-Myers Squibb
• Hoffmann-La Roche AG
• EnGeneIC Ltd
• Celgene Corporation
• ELI Lilly and Company
• Johnson & Johnson
• Merck & Co Inc.
• Novartis
• Pfizer Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Cancer Therapeutics and Biotherapeutics Market

Which Region Dominates the Cancer Therapeutics and Biotherapeutics Market in 2024?

According to Cognitive Market Research, North America currently dominates the Cancer Therapeutics and Biotherapeutics market, and the region is expected to have significant growth during the projected period. Because of its high healthcare costs, robust research infrastructure, and substantial oncology R&D investment, North America is a key region propelling the growth of the cancer therapies and biotherapeutics market. Advanced biotherapeutics like CAR-T cell therapies and immunotherapies are being adopted quickly in the region due to the high frequency of cancer, which increases demand for novel treatments. Market expansion is further accelerated by supportive regulatory frameworks, such as the FDA's fast-track approval process. Furthermore, North America has a strong healthcare system and important pharmaceutical businesses, which contribute significantly to the development of cancer treatments and position the region as a market growth engine.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The market for cancer therapies and biotherapeutics is expected to increase significantly in the Asia Pacific area because of its large ageing population, rising cancer incidence, and expanding healthcare infrastructure. Improved regulatory frameworks in nations like China and India, increased access to cutting-edge medical treatments, and rising disposable incomes are all contributing to the expansion of market prospects. The area is also seeing a boom in biotech investments, clinical studies, and the use of customized cancer treatments. As healthcare systems change and people become more knowledgeable about cancer treatments, Asia Pacific is emerging as a major centre for the creation and dissemination of cutting-edge cancer therapies and biotherapeutics.

The current report Scope analyzes Cancer Therapeutics and Biotherapeutics Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Cancer Therapeutics and Biotherapeutics

According to Cognitive Market Research, the global Cancer Therapeutics and Biotherapeutics market size was estimated at USD 175181.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 70072.60 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Cancer Therapeutics and Biotherapeutics market with a market size of USD 55287.28 million in 2024 and is projected to grow at a CAGR of 6.8% during the forecast period. The United States boasts a strong healthcare system that enables cutting-edge cancer treatments, including gene and immunotherapies.
• The Canadian Cancer Therapeutics and Biotherapeutics market had a market share of USD 8408.71 million in 2024 and is projected to grow at a CAGR of 7.8% during the forecast period. Canada gains access to state-of-the-art cancer treatments through partnerships with US research institutes.
• The Mexico Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 6376.61 million in 2024.

Europe Cancer Therapeutics and Biotherapeutics

According to Cognitive Market Research, the global Cancer Therapeutics and Biotherapeutics market size was estimated at USD 175181.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 52554.45 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031.

• The United Kingdom Cancer Therapeutics and Biotherapeutics market had a market share of USD 8829.15 million in 2024 and is projected to grow at a CAGR of 8.1% during the forecast period. The Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom facilitates the approval of innovative treatments.
• The France Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 4835.01 million in 2024.
• According to Cognitive Market Research, the German Cancer Therapeutics and Biotherapeutics market size was valued at USD 10405.78 million in 2024 and is projected to grow at a CAGR of 7.5% during the forecast period. Germany’s leading pharmaceutical companies drive the development and manufacturing of cancer therapeutics.
• The Italy Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 4519.68 million in 2024.
• The Russia Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 8145.94 million in 2024.
• The Spain Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 6.4% during the forecast period with a market size of USD 4309.46 million in 2024
• The Luxembourg Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 7.4% during the forecast period, with a market size of USD 1629.19 million in 2024.
• The Portugal Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 7.1% during the forecast period, with a market size of USD 1103.64 million in 2024.
• The Greece Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 630.65 million in 2024.
• The Rest of Europe's Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 8145.94 million in 2024.

Asia Pacific Cancer Therapeutics and Biotherapeutics

According to Cognitive Market Research, the global Cancer Therapeutics and Biotherapeutics market size was estimated at USD 175181.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 40291.75 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.8% from 2024 to 2031.

• According to Cognitive Market Research, the China Cancer Therapeutics and Biotherapeutics market size was valued at USD 18131.29 million in 2024 and is projected to grow at a CAGR of 10.3% during the forecast period. Cancer Therapeutics and Biotherapeutics have surged in China due to China's market for cancer biotherapeutics is growing as a result of its emphasis on biotechnology and innovation.
• The Japan Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 9.3% during the forecast period, with a market size of USD 5560.26 million in 2024.
• The India Cancer Therapeutics and Biotherapeutics market had a market share of USD 4835.01 million in 2024 and is projected to grow at a CAGR of 12.6% during the forecast period. The need for creative and reasonably priced cancer treatments is being driven by the rise in cancer cases in India.
• The South Korean Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 9.9% during the forecast period, with a market size of USD 4029.17 million in 2024.
• The Australian Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 10.5% during the forecast period, with a market size of USD 2095.17 million in 2024.
• The South East Asia Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 11.8% during the forecast period, with a market size of USD 2780.13 million in 2024.
• The Rest of Asia Pacific Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 10.6% during the forecast period, with a market size of USD 2860.71 million in 2024.

South America Cancer Therapeutics and Biotherapeutics

According to Cognitive Market Research, the global Cancer Therapeutics and Biotherapeutics market size was estimated at USD 175181.5 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 8759.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Cancer Therapeutics and Biotherapeutics market size was valued at USD 3748.88 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period. Cancer Therapeutics and Biotherapeutics flourished in Brazil due to enhancing cancer care and treatment accessibility is the goal of Brazilian government programs in response to the rising cancer burden.
• Argentina's Cancer Therapeutics and Biotherapeutics market had a market share of USD 1471.52 million in 2024 and is projected to grow at a CAGR of 9.1% during the forecast period. In Argentina, clinical trial management and patient care can be enhanced by the use of digital health technologies.
• Colombia's Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 779.56 million in 2024.
• Peru's Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 8.4% during the forecast period, with a market size of USD 718.24 million in 2024.
• Chile's Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 630.65 million in 2024.
• The Rest of Latin America's Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 1410.21 million in 2024.

Middle East and Africa Cancer Therapeutics and Biotherapeutics

According to Cognitive Market Research, the global Cancer Therapeutics and Biotherapeutics market size was estimated at USD 175181.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 3503.63 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031..

• The GCC Countries Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 9.3% during the forecast period, with a market size of USD 1499.55 million in 2024. Cancer Therapeutics and Biotherapeutics sales flourish in GCC countries due to rising disposable income.
• The Egypt Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 8.8% during the forecast period, with a market size of USD 367.88 million in 2024.
• The South African Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 553.57 million in 2024. Cancer Therapeutics and Biotherapeutics sales flourished in South Africa due to the private healthcare industry making significant investments in cancer treatment centres and treatments.
• The Turkey Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 301.31 million in 2024.
• The Nigeria Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 367.88 million in 2024.
• The Rest of the MEA Cancer Therapeutics and Biotherapeutics market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 413.43 million in 2024.

Cancer Therapeutics and Biotherapeutics Market Analysis

Cancer Therapeutics and Biotherapeutics Market Application Segment Analysis

According to Cognitive Market Research, lung cancer is likely to dominate the Cancer Therapeutics and Biotherapeutics Market over the forecast period. Due to the rising incidence of lung cancer worldwide, the market for cancer therapies and biotherapeutics is expanding quickly. Since lung cancer is one of the most prevalent and fatal tumours, there is a need for novel treatments. Targeted treatments and PD-1/PD-L1 inhibitors are examples of immunotherapies that have demonstrated notable effectiveness in treating advanced non-small cell lung cancer (NSCLC). Monoclonal antibodies and customized therapy are examples of biological treatments that are becoming more and more popular. Patients with small cell and non-small cell lung cancer now have more options and improved survival rates because of new medicines that are being developed as research advances.

Blood cancer is the fastest-growing segment in the Cancer Therapeutics and Biotherapeutics Market. The market for cancer therapeutics and biotherapeutics for blood cancer is growing as a result of improvements in immunotherapies and targeted therapy for diseases like myeloma, lymphoma, and leukemia. Blood cancer care has been transformed by cutting-edge therapies such as immune checkpoint inhibitors, monoclonal antibodies, and CAR-T cell therapy, which give encouraging results for patients with tumours that would otherwise be challenging to treat. The increasing emphasis on genetic profiling and tailored therapy is lowering adverse effects and increasing treatment effectiveness. Blood cancer treatments are expected to make more advances with ongoing research and development, increasing patient quality of life and survival rates.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Cancer Therapeutics and Biotherapeutics Industry. Request a Free Sample PDF!

Cancer Therapeutics and Biotherapeutics Market Therapy Type Segment Analysis

According to Cognitive Market Research, the chemotherapy segment holds the largest share of the market. The market for cancer therapies and biotherapeutics is still seeing high demand for chemotherapy, particularly for tumours such as lung, colorectal, and breast cancer. Chemotherapy continues to be a mainstay of cancer treatment, frequently combined with targeted therapy and immunotherapy. Chemotherapy is crucial in treating cancer at different stages because of its ability to target rapidly dividing cells, even with the advent of more sophisticated medicines. Chemotherapy is still used extensively because of its demonstrated effectiveness, versatility in treating different forms of cancer, and accessibility in medical facilities, even if new treatment options are being developed.

In the Cancer Therapeutics and Biotherapeutics Market, immunotherapy has been expanding at a rapid pace. Because immunotherapy may use the body's immune system to target and kill cancer cells, it is becoming more and more popular in the cancer treatments and biotherapeutics market. Immunotherapies have demonstrated notable success in treating a variety of malignancies, including breast, lung, and melanoma. These include immune checkpoint inhibitors, CAR-T cell treatments, and cancer vaccines. Comparing these medicines to more conventional treatments like chemotherapy, the former provides promising results with fewer adverse effects. Immunotherapy is emerging as a favoured choice, propelling the market expansion for cancer treatments as clinical proof and approval rates increase.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Cancer Therapeutics and Biotherapeutics Application Segment Analysis

Cancer Therapeutics and Biotherapeutics Market Application Segment Analysis

According to Cognitive Market Research, the therapeutics segment is expected to dominate the market. The market for cancer treatments and biotherapeutics includes a range of therapeutic applications, such as hormone therapy, immunotherapy, chemotherapy, and targeted therapy. Breast, lung, blood, and colorectal cancers are among the cancer types for which each strategy is customized. Because of their capacity to stimulate the immune system, immunotherapies such as immune checkpoint inhibitors and CAR-T cell treatments are becoming increasingly popular. Targeted therapies provide precise treatments with fewer side effects by concentrating on particular mutations in cancer cells. Cancers that are driven by hormones, such as prostate and breast cancer, respond well to hormone treatments. These many therapeutic uses mostly drive the market's expansion and innovation.

In the Cancer Therapeutics and Biotherapeutics Market, cell therapy has been expanding at a rapid pace. The success of cutting-edge treatments like CAR-T cell therapy and T-cell receptor therapies is propelling the market for cell therapy in cancer therapeutics and biotherapeutics to tremendous growth. In these treatments, the patient's immune system is altered to more effectively target and eliminate cancer cells. Significant progress has been made with CAR-T cell treatment, especially in blood malignancies like lymphoma and leukemia. Cell therapies are becoming more widely used for solid tumours as research progresses, providing encouraging substitutes for conventional treatments. Cell therapy is one of the major factors propelling the biotherapeutics market due to its promise for highly targeted, customized cancer treatment.

• Therapeutics
• Drug Discovery
• Gene therapy
• IVF treatment
• Cell therapy
• Research & Development

Cancer Therapeutics and Biotherapeutics End User Segment Analysis

Cancer Therapeutics and Biotherapeutics Market End User Segment Analysis

According to Cognitive Market Research, the hospitals & clinics segment holds the largest share of the market. The market for cancer therapies and biotherapeutics is growing quickly for hospitals and clinics as end users because of the rising need for cutting-edge cancer treatments. Chemotherapy, immunotherapy, targeted therapy, and cell therapies are primarily administered in hospitals and speciality cancer clinics. Well-equipped healthcare facilities are necessary due to the rising number of cancer patients and improvements in treatment choices. Furthermore, hospitals and clinics play a key role in personalized medicine by providing customized treatments and genetic testing. The market is expanding as a result of this trend since these organizations are now major suppliers of innovative cancer treatments.

In the Cancer Therapeutics and Biotherapeutics Market, cancer care centres have been expanding at a rapid pace. The market for cancer therapies and biotherapeutics in cancer care facilities is expanding significantly due to the rising need for specialized cancer treatments. In addition to offering cutting-edge therapies like immunotherapy, cell therapies, targeted treatments, and chemotherapy, these facilities offer complete care. As more people are being diagnosed with cancer, patients are looking for the highly specialized care that cancer centres can offer, with an emphasis on individualized treatment programs and state-of-the-art technologies. With their cutting-edge diagnostic and treatment capabilities, these institutes play a significant role in the expanding market for cancer treatments and biotherapeutics..

• Hospitals & Clinics
• Cancer Care Centers
• Research Institutes
• Others

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion